SC
RXST icon

Saturna Capital’s RxSight RXST Stock Holding History

Saturna Capital’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,618
Closed -$243K – 162
2025
Q1 		$243K Hold
9,618
– – ﹤0.01% 142
2024
Q4 		$331K Hold
9,618
– – ﹤0.01% 139
2024
Q3 		$475K Hold
9,618
– – 0.01% 124
2024
Q2 		$579K Sell
9,618
-1,400
-13% -$80K 0.01% 122
2024
Q1 		$568K Hold
11,018
– – 0.01% 129
2023
Q4 		$444K Sell
11,018
-305
-3% -$8.95K 0.01% 134
2023
Q3 		$316K Buy
11,323
+1,100
+11% +$32.8K 0.01% 146
2023
Q2 		$294K Buy
+10,223
New +$227K 0.01% 144
2022
Q4 		– Sell
-14,400
Closed -$173K – 155
2022
Q3 		$173K Hold
14,400
– – ﹤0.01% 152
2022
Q2 		$203K Buy
+14,400
New +$190K ﹤0.01% 155

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Saturna Capital's RXST Position: Q2 2025 in Review

Saturna Capital sold out of RxSight (RXST) in Q2 2025, closing a stake of 9,618 shares — an estimated $243K sold.

Saturna Capital first reported a position in RXST in Q2 2022 and held it in 10 quarters. The position peaked at $579K in Q2 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

  • Saturna Capital reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
  • Saturna Capital sold 9,618 RxSight shares in Q2 2025, an estimated $243K.
  • Saturna Capital first reported a position in RxSight in Q2 2022 and held it in 10 quarters.
  • Saturna Capital's RxSight position peaked at $579K in Q2 2024.
  • 174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on Saturna Capital's 13F filing for Q2 2025, filed 12 Aug 2025.